CoChat

A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α

Open access

Published version of a preprint

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

TRIM5α is a key cross-species barrier to retroviral infection, with certain TRIM5 alleles conferring increased risk of HIV-1 infection in humans. TRIM5α is best known as a species-specific restriction factor that directly inhibits the viral life cycle. Additionally, it is also a pattern-recognition receptor (PRR) that activates inflammatory signaling. How TRIM5α carries out its multi-faceted actions in antiviral defense remains incompletely understood. Here, we show that proteins required for autophagy, a cellular self-digestion pathway, play an important role in TRIM5α's function as a PRR. Genetic depletion of proteins involved in all stages of the autophagy pathway prevented TRIM5α-driven expression of NF-κB and AP1 responsive genes. One of these genes is the preeminent antiviral cytokine interferon β (IFN-β), whose TRIM5-dependent expression was lost in cells lacking the autophagy proteins ATG7, BECN1, and ULK1. Moreover, we found that the ability of TRIM5α to stimulate IFN-β expression in response to recognition of a TRIM5α-restricted HIV-1 capsid mutant (P90A) was abrogated in cells lacking autophagy factors. Stimulation of human macrophage-like cells with the P90A virus protected them against subsequent infection with an otherwise resistant wild type HIV-1 in a manner requiring TRIM5α, BECN1, and ULK1. Mechanistically, TRIM5α was attenuated in its ability to activate the kinase TAK1 in autophagy deficient cells, and both BECN1 and ATG7 contributed to the assembly of TRIM5α-TAK1 complexes. These data demonstrate a non-canonical role for the autophagy machinery in assembling antiviral signaling complexes and in establishing a TRIM5α-dependent antiviral state.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1009017

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Requirement for core autophagy machinery in TRIM5-based activation of inflammatory transcription factors NF-κB and AP1. (A) Schematic of TRIM5-TAK1 signaling axis. (B-D) HEK293T cells were transfected with non-targeting or the indicated siRNA one day prior to transfection with plasmids encoding firefly luciferase under the control of NF-κB- or AP1-responsive promoters, constitutively active Renilla luciferase, and either TRIM5-APEX2 or APEX2 alone. 40–48h after transfection, samples were harvested, and luciferase values determined. Immunoblots to the left indicate knockdown efficiency. Plots show the relative signaling, which is determined by dividing a sample’s firefly luciferase signal by its Renilla luciferase signal. All values are then normalized to the mean of the TRIM5-negative control siRNA-treated sample. Data, each data point represents an independent biological replicate. **, P < 0.01; ****, P < 0.0001; †, not significant by ANOVA.
Fig 1 Requirement for core autophagy machinery in TRIM5-based activation of inflammatory transcription factors NF-κB and AP1. (A) Schematic of TRIM5-TAK1 signaling axis. (B-D) HEK293T cells were transfected with non-targeting or the indicated siRNA one day prior to transfection with plasmids encoding firefly luciferase under the control of NF-κB- or AP1-responsive promoters, constitutively active Renilla luciferase, and either TRIM5-APEX2 or APEX2 alone. 40–48h after transfection, samples were harvested, and luciferase values determined. Immunoblots to the left indicate knockdown efficiency. Plots show the relative signaling, which is determined by dividing a sample’s firefly luciferase signal by its Renilla luciferase signal. All values are then normalized to the mean of the TRIM5-negative control siRNA-treated sample. Data, each data point represents an independent biological replicate. **, P < 0.01; ****, P < 0.0001; †, not significant by ANOVA.CC BY · PubMed Central
Fig 2 Knockout of core autophagy machinery attenuates TRIM5 signaling at the level of TAK1. (A) Immunoblots showing knockouts of ULK1, BECN1, and ATG7 from CRISPR/Cas9-generated HEK293T cells. Control lines were generated expressing Cas9 and non-targeting guide RNAs. (B,C) Control or autophagy factor knockout HEK293T cells were transfected with plasmids encoding firefly luciferase under the control of NF-κB- or AP1-responsive promoters, constitutively active Renilla luciferase, and either TRIM5-APEX2 or APEX2 alone and luciferase activity determined as mentioned previously. (D) Control and knockout HEK293T cells were transfected with NF-κB reporter plasmid and GFP-TRIM5, GFP-TAK1, or GFP alone, with NF-κB signaling as determined above. Data, each data point represents an independent biological replicate. ****, P < 0.0001; †, not significant by ANOVA.
Fig 2 Knockout of core autophagy machinery attenuates TRIM5 signaling at the level of TAK1. (A) Immunoblots showing knockouts of ULK1, BECN1, and ATG7 from CRISPR/Cas9-generated HEK293T cells. Control lines were generated expressing Cas9 and non-targeting guide RNAs. (B,C) Control or autophagy factor knockout HEK293T cells were transfected with plasmids encoding firefly luciferase under the control of NF-κB- or AP1-responsive promoters, constitutively active Renilla luciferase, and either TRIM5-APEX2 or APEX2 alone and luciferase activity determined as mentioned previously. (D) Control and knockout HEK293T cells were transfected with NF-κB reporter plasmid and GFP-TRIM5, GFP-TAK1, or GFP alone, with NF-κB signaling as determined above. Data, each data point represents an independent biological replicate. ****, P < 0.0001; †, not significant by ANOVA.CC BY · PubMed Central
Fig 3 Multiple components of autophagy/lysosome system are involved in TRIM5 signaling. (A-E) The effect of the indicated knockdowns on TRIM5-mediated NF-κB and AP1 activation in a dual luciferase reporter assay system. Immunoblots demonstrating knockdown efficiency are shown in S1C Fig. (F) HEK293T cells were transfected as above and treated or not with the protease inhibitors e64d and pepstatin A (PepA) for 48 h prior to lysis. Both inhibitors were use at a concentration of 10 μM. Luciferase activity determined as above. Each data point represents an independent biological replicate. *, P < 0.05; **, P < 0.01; ****, P < 0.0001; †, not significant by ANOVA.
Fig 3 Multiple components of autophagy/lysosome system are involved in TRIM5 signaling. (A-E) The effect of the indicated knockdowns on TRIM5-mediated NF-κB and AP1 activation in a dual luciferase reporter assay system. Immunoblots demonstrating knockdown efficiency are shown in S1C Fig. (F) HEK293T cells were transfected as above and treated or not with the protease inhibitors e64d and pepstatin A (PepA) for 48 h prior to lysis. Both inhibitors were use at a concentration of 10 μM. Luciferase activity determined as above. Each data point represents an independent biological replicate. *, P < 0.05; **, P < 0.01; ****, P < 0.0001; †, not significant by ANOVA.CC BY · PubMed Central
Fig 4 Autophagy factors are required for TRIM5-driven inflammatory gene expression in macrophages. (A) Differentiated THP-1 cell lines stably expressing APEX2-V5 alone or APEX2-V5 tagged TRIM5 (human or rhesus) were infected with HIV-GFP and the percentage of infected (GFP-positive) cells was determined by high content imaging. White mask, automatically identified cell boundaries. Scale bar, 50 μm. Plot, the mean above-background GFP intensity per cell (a measure of transduction efficiency) following infection of increasing amounts of HIV-GFP. N = 5 independent biological replicates, >500 cells analyzed per replicate. (B-D) Quantitative PCR analysis of THP-1 macrophage cells stably transduced with lentiviruses expressing rhesus or human TRIM5 fused to APEX2 or APEX2 alone and subjected to the indicated siRNA-mediated knockdowns. The abundance of IFNB1 (B), NLRP1 (C), and IL6 (D) were determined relative to the abundance of 18S ribosomal RNA. Quantitative PCR analysis of knockdown efficiency is shown in S2C and S2D Fig. Data, each data point represents an independent biological replicate; *, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001; †, not significant by ANOVA.
Fig 4 Autophagy factors are required for TRIM5-driven inflammatory gene expression in macrophages. (A) Differentiated THP-1 cell lines stably expressing APEX2-V5 alone or APEX2-V5 tagged TRIM5 (human or rhesus) were infected with HIV-GFP and the percentage of infected (GFP-positive) cells was determined by high content imaging. White mask, automatically identified cell boundaries. Scale bar, 50 μm. Plot, the mean above-background GFP intensity per cell (a measure of transduction efficiency) following infection of increasing amounts of HIV-GFP. N = 5 independent biological replicates, >500 cells analyzed per replicate. (B-D) Quantitative PCR analysis of THP-1 macrophage cells stably transduced with lentiviruses expressing rhesus or human TRIM5 fused to APEX2 or APEX2 alone and subjected to the indicated siRNA-mediated knockdowns. The abundance of IFNB1 (B), NLRP1 (C), and IL6 (D) were determined relative to the abundance of 18S ribosomal RNA. Quantitative PCR analysis of knockdown efficiency is shown in S2C and S2D Fig. Data, each data point represents an independent biological replicate; *, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001; †, not significant by ANOVA.CC BY · PubMed Central
Fig 5 TRIM5 actions as a pattern-recognition receptor require autophagy factors. (A) Effect of TRIM5 knockout on the ability of HIV-1 CA P90A and WT HIV-1 to infect THP-1 macrophages. Control or TRIM5 KO cells (lines 1 and 2) were PMA-differentiated and then infected with single-cycle fluorescent protein-expressing pseudovirions for two days (CrFK MOI = 1). The percentage of cells showing red fluorescence (P90A) or green fluorescence (HIV WT) was determined by high content imaging 2 days post infection. Each data point represents the results from an individual well of a 96-well plate (>2000 cells analyzed per well). TRIM5 KO line 2 was used for subsequent experiments. (B) The effect of HIV-1 P90A infection on the expression of inflammatory gene IFNB1 in THP-1 macrophages expressing or not autophagy factors and TRIM5. THP-1 cell lines knocked out for the autophagy factors ULK1, BECN1, ATG7 or TRIM5 (or control) were PMA-differentiated and then exposed to HIV-1 CA P90A for two hours (CrFK MOI = 3) prior to RNA isolation and qPCR analysis. 18S ribosomal RNA was used as a normalization control. Data, each data point represents an independent biological replicate; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001; †, not significant by ANOVA.
Fig 5 TRIM5 actions as a pattern-recognition receptor require autophagy factors. (A) Effect of TRIM5 knockout on the ability of HIV-1 CA P90A and WT HIV-1 to infect THP-1 macrophages. Control or TRIM5 KO cells (lines 1 and 2) were PMA-differentiated and then infected with single-cycle fluorescent protein-expressing pseudovirions for two days (CrFK MOI = 1). The percentage of cells showing red fluorescence (P90A) or green fluorescence (HIV WT) was determined by high content imaging 2 days post infection. Each data point represents the results from an individual well of a 96-well plate (>2000 cells analyzed per well). TRIM5 KO line 2 was used for subsequent experiments. (B) The effect of HIV-1 P90A infection on the expression of inflammatory gene IFNB1 in THP-1 macrophages expressing or not autophagy factors and TRIM5. THP-1 cell lines knocked out for the autophagy factors ULK1, BECN1, ATG7 or TRIM5 (or control) were PMA-differentiated and then exposed to HIV-1 CA P90A for two hours (CrFK MOI = 3) prior to RNA isolation and qPCR analysis. 18S ribosomal RNA was used as a normalization control. Data, each data point represents an independent biological replicate; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001; †, not significant by ANOVA.CC BY · PubMed Central
Fig 6 Stimulation of TRIM5 signaling induces an antiviral state. (A) Schematic overview of experimental model for sequential viral “priming and challenge” experiments. PMA-differentiated THP-1 macrophages were cultured in the presence of the “priming” virus for 24 hours prior to subsequent “challenge” with GFP-expressing WT HIV-1 for next 48h. The percentage of cells showing GFP-positivity was determined by high content imaging. (B,C) THP-1 cells were primed with HIV-1 CA P90A (CrFK MOI = 3) prior to challenge with different CrFK MOI of WT HIV-1. Representative images (B) of mock infected, infected, or primed and infected cells captured by high content imager. Scale bar, 50 μm. Plot (C) shows the percentage of cells that become GFP-positive following infection with the challenge virus. (D) THP-1 cells were primed with VSV-G pseudotyped N-MLV (CrFK MOI = 0.5) and then challenged with WT HIV-1 at the indicated MOI. For C and D, each data point represents one well of a 96-well plate with >2000 cells analyzed per well. Data shown is from one representative experiment of 3. See also S4A and S4B Fig. (E) Differentiated THP-1 cells were primed or not with HIV-1 CA WT (TRIM5 resistant) or P90A (TRIM5 sensitive) and then challenged with HIV-1 GFP. The data are expressed as the ratio of infected cells before priming to relative to what is seen in unprimed cells (relative restriction). (F) The effect of TRIM5 knockout on the ability of priming with HIV-1 CA P90A to protect THP-1 macrophages from infection with WT HIV-1 GFP. (G) The relative restriction seen in P90A primed WT or TRIM5 KO THP-1 macrophages stably expressing APEX2 or TRIM5-APEX2 (TRIM5 add-back). For panels E-G, priming virus was used at a CrFK MOI of 3 and HIV-GFP infections were performed at a CrFK MOI of 1. (H) Q-RT PCR analysis of the impact of P90A (CrFK MOI = 3) or poly(I:C) priming on the permissivity of WT or TRIM5 KO THP-1 macrophages to Sendai virus infection. **, P < 0.01; ***, P < 0.001, ****, P < 0.0001; †, not significant by t test or ANOVA.
Fig 6 Stimulation of TRIM5 signaling induces an antiviral state. (A) Schematic overview of experimental model for sequential viral “priming and challenge” experiments. PMA-differentiated THP-1 macrophages were cultured in the presence of the “priming” virus for 24 hours prior to subsequent “challenge” with GFP-expressing WT HIV-1 for next 48h. The percentage of cells showing GFP-positivity was determined by high content imaging. (B,C) THP-1 cells were primed with HIV-1 CA P90A (CrFK MOI = 3) prior to challenge with different CrFK MOI of WT HIV-1. Representative images (B) of mock infected, infected, or primed and infected cells captured by high content imager. Scale bar, 50 μm. Plot (C) shows the percentage of cells that become GFP-positive following infection with the challenge virus. (D) THP-1 cells were primed with VSV-G pseudotyped N-MLV (CrFK MOI = 0.5) and then challenged with WT HIV-1 at the indicated MOI. For C and D, each data point represents one well of a 96-well plate with >2000 cells analyzed per well. Data shown is from one representative experiment of 3. See also S4A and S4B Fig. (E) Differentiated THP-1 cells were primed or not with HIV-1 CA WT (TRIM5 resistant) or P90A (TRIM5 sensitive) and then challenged with HIV-1 GFP. The data are expressed as the ratio of infected cells before priming to relative to what is seen in unprimed cells (relative restriction). (F) The effect of TRIM5 knockout on the ability of priming with HIV-1 CA P90A to protect THP-1 macrophages from infection with WT HIV-1 GFP. (G) The relative restriction seen in P90A primed WT or TRIM5 KO THP-1 macrophages stably expressing APEX2 or TRIM5-APEX2 (TRIM5 add-back). For panels E-G, priming virus was used at a CrFK MOI of 3 and HIV-GFP infections were performed at a CrFK MOI of 1. (H) Q-RT PCR analysis of the impact of P90A (CrFK MOI = 3) or poly(I:C) priming on the permissivity of WT or TRIM5 KO THP-1 macrophages to Sendai virus infection. **, P < 0.01; ***, P < 0.001, ****, P < 0.0001; †, not significant by t test or ANOVA.CC BY · PubMed Central
Fig 7 The establishment of a TRIM5-dependent antiviral state requires autophagy factors. Control or knockout THP-1 macrophages were primed with P90A (CrFK MOI 3) for 24 hours prior to infection with WT HIV-GFP (CrFK MOI 1) for two days. (A) Representative images from high content imager showing HIV-GFP exposed primed or unprimed THP-1 cell lines. Scale bar, 50 μm. (B) The percentage of cells showing GFP-positivity. Each data point represents one well of a 96 well plate (>2000 cells analyzed). Data shown is from one representative experiment. (C) The relative restriction imposed by P90A priming in control THP-1 macrophages or in THP-1 cell lines knocked out for the indicated genes as shown in (A,B). N = 4 independent experiments. (D) The impact of NF-κB, AP1, and autophagy inhibition on P90A-induced restriction. THP-1 cells were treated with BAY 117085 (NF-κB inhibitor; 10 μM), SP600125 (JNK/AP1 inhibitor; 10 μM) or 3-methyladenine (PI3 kinase/autophagy inhibitor; 1 mM) or DMSO (vehicle control) for 1 h prior to infection with P90A or mock infection. See also S4G Fig. Data, mean + SEM. N = 4 independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; †, not significant by ANOVA.
Fig 7 The establishment of a TRIM5-dependent antiviral state requires autophagy factors. Control or knockout THP-1 macrophages were primed with P90A (CrFK MOI 3) for 24 hours prior to infection with WT HIV-GFP (CrFK MOI 1) for two days. (A) Representative images from high content imager showing HIV-GFP exposed primed or unprimed THP-1 cell lines. Scale bar, 50 μm. (B) The percentage of cells showing GFP-positivity. Each data point represents one well of a 96 well plate (>2000 cells analyzed). Data shown is from one representative experiment. (C) The relative restriction imposed by P90A priming in control THP-1 macrophages or in THP-1 cell lines knocked out for the indicated genes as shown in (A,B). N = 4 independent experiments. (D) The impact of NF-κB, AP1, and autophagy inhibition on P90A-induced restriction. THP-1 cells were treated with BAY 117085 (NF-κB inhibitor; 10 μM), SP600125 (JNK/AP1 inhibitor; 10 μM) or 3-methyladenine (PI3 kinase/autophagy inhibitor; 1 mM) or DMSO (vehicle control) for 1 h prior to infection with P90A or mock infection. See also S4G Fig. Data, mean + SEM. N = 4 independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; †, not significant by ANOVA.CC BY · PubMed Central
Fig 8 Autophagy factors scaffold TRIM5 interactions with TAK1 and promote TAK1 activation. (A) Immunoblot analysis of the impact of TRIM5 expression on TAK1 activation in control and autophagy factor knockout HEK293T cells. Lysates from cells transiently transfected with GFP-TAK1 and either APEX2-alone or TRIM5-APEX2 were immunoblotted and probed with the indicated antibodies. Right, the abundance of active phospho-TAK1 (phospho-Thr184/187) relative to total GFP-TAK1. N = 3 experiments. (B) Confocal microscopic analysis of GFP-TAK1, TRIM5-HA (rhesus; blue), and endogenous p62 (red) in HeLa cells. Dashed box, region shown in zoomed-in insets. Scale bar, 5 μm. (C) Confocal microscopic analysis of GFP-TAK1, Myc-ULK1 (red) in HeLa cells that stably express TRIM5-HA (blue). Dashed box, indicates regions shown in zoomed-in insets (right). Scale bar, 5 μm. (D, E) Co-immunoprecipitation analysis of interactions between FLAG-TAK1 and GFP-TRIM5 in WT and autophagy factor KO cells. GFP-TRIM5 was immunoprecipitated in (D) and FLAG-TAK1 was immunoprecipitated in (E). Plots show the abundance of the immunoprecipitated protein (FLAG-TAK1 in D and GFP-TRIM5 in E) relative to that protein’s abundance in the input. N = 3 independent experiments. (F) Immunoblot analysis of the impact of WT or LIR2 mutant (WE196AA) TRIM5 on the abundance of active phospho-TAK1 (phospho-Thr184/187). Plot shows the abundance of phospho-TAK1 relative to that of FLAG-TAK1. N = 3 independent experiments. (G) The impact of WT or LIR2 mutant TRIM5 on the activation of an NF-κB luciferase reporter. Each data point represents an independent biological replicate. *, P < 0.05; **, P < 0.01; ****, P < 0.0001 by ANOVA.
Fig 8 Autophagy factors scaffold TRIM5 interactions with TAK1 and promote TAK1 activation. (A) Immunoblot analysis of the impact of TRIM5 expression on TAK1 activation in control and autophagy factor knockout HEK293T cells. Lysates from cells transiently transfected with GFP-TAK1 and either APEX2-alone or TRIM5-APEX2 were immunoblotted and probed with the indicated antibodies. Right, the abundance of active phospho-TAK1 (phospho-Thr184/187) relative to total GFP-TAK1. N = 3 experiments. (B) Confocal microscopic analysis of GFP-TAK1, TRIM5-HA (rhesus; blue), and endogenous p62 (red) in HeLa cells. Dashed box, region shown in zoomed-in insets. Scale bar, 5 μm. (C) Confocal microscopic analysis of GFP-TAK1, Myc-ULK1 (red) in HeLa cells that stably express TRIM5-HA (blue). Dashed box, indicates regions shown in zoomed-in insets (right). Scale bar, 5 μm. (D, E) Co-immunoprecipitation analysis of interactions between FLAG-TAK1 and GFP-TRIM5 in WT and autophagy factor KO cells. GFP-TRIM5 was immunoprecipitated in (D) and FLAG-TAK1 was immunoprecipitated in (E). Plots show the abundance of the immunoprecipitated protein (FLAG-TAK1 in D and GFP-TRIM5 in E) relative to that protein’s abundance in the input. N = 3 independent experiments. (F) Immunoblot analysis of the impact of WT or LIR2 mutant (WE196AA) TRIM5 on the abundance of active phospho-TAK1 (phospho-Thr184/187). Plot shows the abundance of phospho-TAK1 relative to that of FLAG-TAK1. N = 3 independent experiments. (G) The impact of WT or LIR2 mutant TRIM5 on the activation of an NF-κB luciferase reporter. Each data point represents an independent biological replicate. *, P < 0.05; **, P < 0.01; ****, P < 0.0001 by ANOVA.CC BY · PubMed Central
Fig 9 Model of how autophagy contributes to TRIM5-TAK1 signaling and the establishment of an antiviral state. (A) TRIM5-sensitive retroviral cores are recognized by TRIM5, leading to direct capsid-specific restriction and triggering a signal transduction cascade that results in the establishment of a general antiviral state. While TRIM5 over-expression can mimic some aspects of viral recognition by TRIM5, it is insufficient to enable viral restriction by TRIM5-resistant viruses. (B) Autophagy-dependent assembly of TRIM5-TAK1 complexes that result in TAK1 activation by TRIM5. The various protein-protein interactions depicted are based on findings in this work and in previous reports. Autophagic degradation of negative regulators of TRIM5-TAK1 signaling may also contribute.
Fig 9 Model of how autophagy contributes to TRIM5-TAK1 signaling and the establishment of an antiviral state. (A) TRIM5-sensitive retroviral cores are recognized by TRIM5, leading to direct capsid-specific restriction and triggering a signal transduction cascade that results in the establishment of a general antiviral state. While TRIM5 over-expression can mimic some aspects of viral recognition by TRIM5, it is insufficient to enable viral restriction by TRIM5-resistant viruses. (B) Autophagy-dependent assembly of TRIM5-TAK1 complexes that result in TAK1 activation by TRIM5. The various protein-protein interactions depicted are based on findings in this work and in previous reports. Autophagic degradation of negative regulators of TRIM5-TAK1 signaling may also contribute.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 18

Metadata

Authors
Saha, B., Chisholm, D., Kell, A. M., & Mandell, M. A.
Affiliations
University of New Mexico (US)
Corresponding author
Mandell, Michael A.
Venue
PLOS Pathogens
Published
2020-10-14
Volume
16
Issue
10
Pages
e1009017
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W3093125577
Cited by
16
References
47
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2022: 3 · 2021: 7
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of General Medical Sciences (1P20GM121176-02)
  • National Institute of Allergy and Infectious Diseases (1R21AI131964-01A1, 1K22AI141680-01A1)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
TRIM5α, autophagy, HIV-1, pattern recognition receptors, interferon-beta, NF-κB signaling, AP-1, Beclin-1, ATG7, ULK1, antiviral signaling, macrophages, antiviral state, retroviral restriction factors
MeSH terms
Tripartite Motif Proteins, Beclin-1, Autophagy-Related Protein-1 Homolog, THP-1 Cells, Antiviral Restriction Factors, Autophagy, Capsid, Carrier Proteins, Cell Line, HeLa Cells, Humans, Peptides, Retroviridae Infections, Species Specificity, HIV-1, HIV Infections, NF-kappa B, Interferon-beta, Capsid Proteins, Ubiquitin-Protein Ligases, Intracellular Signaling Peptides and Proteins, Receptors, Pattern Recognition, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.